Short communicationExpression of CD40 in the brain of Alzheimer’s disease and other neurological diseases
Section snippets
Acknowledgements
This research was supported by grants-in-aid from the Ministry of Education, Science and Culture of Japan (10670618).
References (18)
- et al.
Alzheimer’s β-amyloid peptides induce inflammatory cascade in human vascular cells: the role of cytokines and CD40
Brain Res.
(1998) - et al.
Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis
J. Neuroimmunol.
(1999) - et al.
Induction of CD40 on human endothelial cells by Alzheimer’s β-amyloid peptides
Brain Res. Bull.
(1999) - et al.
CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40
J. Exp. Med.
(1993) - et al.
CD40–CD154 interaction and IFN-γ are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells
J. Immunol.
(1999) - et al.
Antibodies to distinct epitopes on the CD40 molecule co-operate in stimulation and can be used for the detection of soluble CD40
Immunology
(1994) - et al.
Mature microglia resemble immature antigen-presenting cells
Glia
(1998) - et al.
Activation of human dendritic cells through CD40 cross-linking
J. Exp. Med.
(1994) - et al.
CD40 is functionally expressed on human thymic epithelial cells
J. Immunol.
(1992)
Cited by (116)
Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluid
2020, Neurobiology of AgingCitation Excerpt :These were enriched for cytokine-cytokine interactions. Cytokines play a major role in inflammatory and anti-inflammatory processes and are dysregulated in AD (Kauwe et al., 2014; Rubio-Perez and Morillas-Ruiz, 2012; Tarkowski et al., 2000; Togo et al., 2000; Zetterberg et al., 2004). The notion that these proteins were associated with PGRS that included the weakest SNPs suggests that many different SNPs may lead to inflammatory processes as observed in AD.
Molecular alterations in the medial temporal lobe in schizophrenia
2020, Schizophrenia ResearchCitation Excerpt :On the other hand, microglial markers have also been reduced in a few studies either throughout the hippocampus (Morgan et al., 2016) or in specific subfields like CA1 or CA3 (Benes et al., 2007; Gos et al., 2014). Several studies have found no change in either number of microglia in hippocampus in individuals with schizophrenia (Steiner et al., 2006) or proinflammatory gene markers (Togo et al., 2000; Yokota et al., 2004) and cell types which exert immunological function (Arnold et al., 1996; Schmitt et al., 2009). In a meta-analysis of postmortem brain studies examining factors related to the immune system in individuals with schizophrenia and matched healthy controls, there was no significant change in overall expression of proinflammatory genes in the hippocampus (van Kesteren et al., 2017).
Blood-Brain Barrier: Genomics, Proteomics, Disease Targets, and Drug Delivery
2017, Nanotechnology Methods for Neurological Diseases and Brain Tumors: Drug Delivery across the Blood-Brain BarrierThe role of microglia in the pathobiology of neuropathic pain development: What do we know?
2017, British Journal of AnaesthesiaMicroglia in Alzheimer's disease: A multifaceted relationship
2016, Brain, Behavior, and Immunity